Forecast & Rating2 analysts currently cover Dizal Pharmaceutical, of which 2 give a positive rating. The average price target is ¥83.00, about 35.5% upside from the current price of ¥61.24. Coverage is limited, so the data is for reference only. Data as of Aug 3, 2026; this does not constitute investment advice.
Jul 31, 2026Price forecast
¥83.0035.53%
Forecast & RatingBuy
2analysts
- Strong buy50.00%
- Buy50.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 16, 2026
Forecast met58.3%
Stock price$61.24
Avg. target$83.0
High target$83
Low target$83
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.